CD44 and neoplasm: The expression of CD133 and CD44 was used to identify CSCs, increases in cytokine levels in bone marrow after intra-cardiac injection of tumor cells quickly returns to basal levels, using BrdU labeling CSCs had a lower proliferation rate compared with non-stem cell tumor cells, nor was there evidence that there was selective homing of CSCs or increased survival in the circulation [104].